Woodline Partners »

MetLife shares owned by Woodline Partners

Quarter-by-quarter ownership of MetLife (MET) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in MetLife

Tip: Access up to 7 years of quarterly data

All positions including MetLife held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in MetLife by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $79M 963k 82.48

More positions owned by Woodline Partners

Meta Platforms Cl A (META)
Gilead Sciences (GILD)
Abbvie (ABBV)
Revolution Medicines (RVMD)
Vaxcyte (PCVX)
Asml Holding N V N Y Registry Shs (ASML)
Nuvalent Inc-a (NUVL)
Permian Resources Corp Class A Com (PR)
Encana Corporation (OVV)
Keysight Technologies (KEYS)
Danaher Corporation (DHR)
Aon Shs Cl A (AON)
Stmicroelectronics N V Ny Registry (STM)
Regeneron Pharmaceuticals (REGN)
EQT Corporation (EQT)

View all positions for Woodline Partners

Top funds holding MetLife

Vanguard Group
Dodge & Cox
BlackRock
BlackRock
State Street Corporation
Jpmorgan Chase & Co
T. Rowe Price Associates
Geode Capital Management
Morgan Stanley
Pzena Investment Management
Invesco
Dimensional Fund Advisors
Bank of America Corporation
Northern Trust
Nuveen Asset Management

View all funds holding MetLife